Fulgent Genetics's total assets for Q2 2026 were $1.09B, a decrease of -5.81% from the previous quarter. DE:7F0 total liabilities were $93.24M for the fiscal quarter, a -16.91% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.